Third Affiliated Hospital, Sun Yat-sen University

This study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The approach combines a targeted drug (bevacizumab), an immunotherapy (adebrelimab), and two liver-directed procedures (TACE and HAIC) to shrink tumors and control the diseas…

This early-stage study tests whether a concentrated dose of a patient's own growth factors can help repair spinal cord damage. Ten adults with traumatic spinal cord injuries will receive the treatment, and researchers will track changes in their motor function. The goal is to fin…

This study tests a new first-line treatment for people with advanced liver cancer that cannot be removed by surgery. The treatment combines a procedure that delivers chemotherapy directly to the tumor (TACE) with two drugs that boost the immune system and block blood vessel growt…

This study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The treatment combines low doses of two drugs (bevacizumab and atezolizumab) with a procedure that delivers chemotherapy directly to the liver. The goal is to see if this app…

This study tests whether a virtual health community can help adults with prediabetes improve blood sugar control and prevent type 2 diabetes. Participants will receive lifestyle guidance, health education, and group support through a digital platform for 6 months. The goal is to …